nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—Cisplatin—germ cell cancer	0.18	0.504	CbGbCtD
Clodronate—PTGS2—Etoposide—germ cell cancer	0.176	0.495	CbGbCtD
Clodronate—Acute myeloid leukaemia—Ifosfamide—germ cell cancer	0.0193	0.0723	CcSEcCtD
Clodronate—SLC25A6—Vinorelbine—Vinblastine—germ cell cancer	0.0161	1	CbGdCrCtD
Clodronate—SLC25A6—neck—germ cell cancer	0.0119	0.033	CbGeAlD
Clodronate—Acute leukaemia—Ifosfamide—germ cell cancer	0.0111	0.0415	CcSEcCtD
Clodronate—SLC25A5—neck—germ cell cancer	0.0104	0.0287	CbGeAlD
Clodronate—SLC25A6—embryo—germ cell cancer	0.00992	0.0275	CbGeAlD
Clodronate—Acute leukaemia—Cisplatin—germ cell cancer	0.00957	0.0358	CcSEcCtD
Clodronate—SLC25A6—brainstem—germ cell cancer	0.00909	0.0252	CbGeAlD
Clodronate—SLC25A5—trigeminal ganglion—germ cell cancer	0.00894	0.0248	CbGeAlD
Clodronate—SLC25A6—eye—germ cell cancer	0.00885	0.0246	CbGeAlD
Clodronate—Acute leukaemia—Etoposide—germ cell cancer	0.00877	0.0328	CcSEcCtD
Clodronate—SLC25A5—embryo—germ cell cancer	0.00863	0.0239	CbGeAlD
Clodronate—SLC25A6—telencephalon—germ cell cancer	0.00807	0.0224	CbGeAlD
Clodronate—SLC25A6—skin of body—germ cell cancer	0.0077	0.0214	CbGeAlD
Clodronate—SLC25A5—eye—germ cell cancer	0.0077	0.0214	CbGeAlD
Clodronate—SLC25A4—eye—germ cell cancer	0.00722	0.02	CbGeAlD
Clodronate—SLC25A4—retina—germ cell cancer	0.00715	0.0198	CbGeAlD
Clodronate—SLC25A5—telencephalon—germ cell cancer	0.00702	0.0195	CbGeAlD
Clodronate—SLC25A6—gonad—germ cell cancer	0.00674	0.0187	CbGeAlD
Clodronate—Local reaction—Bleomycin—germ cell cancer	0.0067	0.0251	CcSEcCtD
Clodronate—SLC25A5—skin of body—germ cell cancer	0.0067	0.0186	CbGeAlD
Clodronate—SLC25A6—uterus—germ cell cancer	0.00669	0.0186	CbGeAlD
Clodronate—SLC25A5—decidua—germ cell cancer	0.00666	0.0185	CbGeAlD
Clodronate—SLC25A4—telencephalon—germ cell cancer	0.00658	0.0182	CbGeAlD
Clodronate—SLC25A4—decidua—germ cell cancer	0.00624	0.0173	CbGeAlD
Clodronate—SLC25A6—adrenal gland—germ cell cancer	0.00587	0.0163	CbGeAlD
Clodronate—SLC25A5—gonad—germ cell cancer	0.00586	0.0163	CbGeAlD
Clodronate—SLC25A5—uterus—germ cell cancer	0.00582	0.0161	CbGeAlD
Clodronate—SLC25A5—pituitary gland—germ cell cancer	0.00572	0.0159	CbGeAlD
Clodronate—SLC25A6—bone marrow—germ cell cancer	0.00568	0.0158	CbGeAlD
Clodronate—SLC25A6—spinal cord—germ cell cancer	0.00566	0.0157	CbGeAlD
Clodronate—SLC25A5—medulla oblongata—germ cell cancer	0.00552	0.0153	CbGeAlD
Clodronate—SLC25A4—gonad—germ cell cancer	0.00549	0.0152	CbGeAlD
Clodronate—SLC25A6—female gonad—germ cell cancer	0.00547	0.0152	CbGeAlD
Clodronate—SLC25A4—pituitary gland—germ cell cancer	0.00536	0.0149	CbGeAlD
Clodronate—SLC25A4—medulla oblongata—germ cell cancer	0.00517	0.0143	CbGeAlD
Clodronate—Serum creatinine increased—Ifosfamide—germ cell cancer	0.00516	0.0193	CcSEcCtD
Clodronate—SLC25A5—adrenal gland—germ cell cancer	0.00511	0.0142	CbGeAlD
Clodronate—SLC25A6—endocrine gland—germ cell cancer	0.00509	0.0141	CbGeAlD
Clodronate—SLC25A5—midbrain—germ cell cancer	0.00504	0.014	CbGeAlD
Clodronate—Extravasation—Vinblastine—germ cell cancer	0.00504	0.0189	CcSEcCtD
Clodronate—SLC25A6—head—germ cell cancer	0.00503	0.0139	CbGeAlD
Clodronate—SLC25A5—bone marrow—germ cell cancer	0.00494	0.0137	CbGeAlD
Clodronate—SLC25A5—spinal cord—germ cell cancer	0.00492	0.0136	CbGeAlD
Clodronate—PTGS2—appendage—germ cell cancer	0.0049	0.0136	CbGeAlD
Clodronate—SLC25A6—testis—germ cell cancer	0.00486	0.0135	CbGeAlD
Clodronate—SLC25A4—adrenal gland—germ cell cancer	0.00479	0.0133	CbGeAlD
Clodronate—SLC25A5—female gonad—germ cell cancer	0.00476	0.0132	CbGeAlD
Clodronate—SLC25A4—midbrain—germ cell cancer	0.00473	0.0131	CbGeAlD
Clodronate—SLC25A4—spinal cord—germ cell cancer	0.00461	0.0128	CbGeAlD
Clodronate—SLC25A6—cerebellum—germ cell cancer	0.00448	0.0124	CbGeAlD
Clodronate—SLC25A4—female gonad—germ cell cancer	0.00446	0.0124	CbGeAlD
Clodronate—Serum creatinine increased—Cisplatin—germ cell cancer	0.00445	0.0166	CcSEcCtD
Clodronate—SLC25A5—endocrine gland—germ cell cancer	0.00443	0.0123	CbGeAlD
Clodronate—SLC25A5—head—germ cell cancer	0.00437	0.0121	CbGeAlD
Clodronate—Extravasation—Bleomycin—germ cell cancer	0.00425	0.0159	CcSEcCtD
Clodronate—SLC25A5—testis—germ cell cancer	0.00422	0.0117	CbGeAlD
Clodronate—SLC25A4—endocrine gland—germ cell cancer	0.00415	0.0115	CbGeAlD
Clodronate—SLC25A4—head—germ cell cancer	0.0041	0.0114	CbGeAlD
Clodronate—PTGS2—skin epidermis—germ cell cancer	0.00407	0.0113	CbGeAlD
Clodronate—Extravasation—Dactinomycin—germ cell cancer	0.00397	0.0148	CcSEcCtD
Clodronate—SLC25A4—testis—germ cell cancer	0.00396	0.011	CbGeAlD
Clodronate—SLC25A5—cerebellum—germ cell cancer	0.0039	0.0108	CbGeAlD
Clodronate—Hypocalcaemia—Dactinomycin—germ cell cancer	0.00378	0.0142	CcSEcCtD
Clodronate—Neoplasm malignant—Ifosfamide—germ cell cancer	0.00371	0.0139	CcSEcCtD
Clodronate—SLC25A4—cerebellum—germ cell cancer	0.00366	0.0101	CbGeAlD
Clodronate—SLC25A6—brain—germ cell cancer	0.00364	0.0101	CbGeAlD
Clodronate—Extravasation—Ifosfamide—germ cell cancer	0.00364	0.0136	CcSEcCtD
Clodronate—Proteinuria—Ifosfamide—germ cell cancer	0.00361	0.0135	CcSEcCtD
Clodronate—Wheezing—Bleomycin—germ cell cancer	0.0036	0.0135	CcSEcCtD
Clodronate—Protein urine present—Ifosfamide—germ cell cancer	0.00356	0.0133	CcSEcCtD
Clodronate—SLC25A6—lymph node—germ cell cancer	0.00352	0.00976	CbGeAlD
Clodronate—Hypocalcaemia—Ifosfamide—germ cell cancer	0.00346	0.013	CcSEcCtD
Clodronate—SLC25A5—brain—germ cell cancer	0.00317	0.00879	CbGeAlD
Clodronate—Extravasation—Cisplatin—germ cell cancer	0.00313	0.0117	CcSEcCtD
Clodronate—SLC25A5—lymph node—germ cell cancer	0.00306	0.00849	CbGeAlD
Clodronate—SLC25A4—brain—germ cell cancer	0.00297	0.00823	CbGeAlD
Clodronate—PTGS2—endothelium—germ cell cancer	0.00296	0.0082	CbGeAlD
Clodronate—Extravasation—Etoposide—germ cell cancer	0.00287	0.0107	CcSEcCtD
Clodronate—SLC25A4—lymph node—germ cell cancer	0.00287	0.00796	CbGeAlD
Clodronate—Hepatocellular injury—Cisplatin—germ cell cancer	0.00273	0.0102	CcSEcCtD
Clodronate—PTGS2—blood vessel—germ cell cancer	0.00273	0.00756	CbGeAlD
Clodronate—Wheezing—Cisplatin—germ cell cancer	0.00266	0.00994	CcSEcCtD
Clodronate—Hepatic function abnormal—Ifosfamide—germ cell cancer	0.00263	0.00986	CcSEcCtD
Clodronate—Renal failure acute—Ifosfamide—germ cell cancer	0.00249	0.00933	CcSEcCtD
Clodronate—Renal impairment—Ifosfamide—germ cell cancer	0.00242	0.00906	CcSEcCtD
Clodronate—Cardiac failure—Ifosfamide—germ cell cancer	0.00236	0.00883	CcSEcCtD
Clodronate—Bronchospasm—Bleomycin—germ cell cancer	0.00229	0.00857	CcSEcCtD
Clodronate—Liver disorder—Methotrexate—germ cell cancer	0.0022	0.00824	CcSEcCtD
Clodronate—Pharyngitis—Vinblastine—germ cell cancer	0.00219	0.0082	CcSEcCtD
Clodronate—Dysphagia—Dactinomycin—germ cell cancer	0.00217	0.00813	CcSEcCtD
Clodronate—Blood creatinine increased—Ifosfamide—germ cell cancer	0.00216	0.00807	CcSEcCtD
Clodronate—Renal failure acute—Cisplatin—germ cell cancer	0.00215	0.00805	CcSEcCtD
Clodronate—Pneumonia—Bleomycin—germ cell cancer	0.00209	0.00782	CcSEcCtD
Clodronate—Bronchospasm—Ifosfamide—germ cell cancer	0.00196	0.00733	CcSEcCtD
Clodronate—Pneumonia—Dactinomycin—germ cell cancer	0.00195	0.00729	CcSEcCtD
Clodronate—Cardiac failure—Etoposide—germ cell cancer	0.00186	0.00697	CcSEcCtD
Clodronate—Blood creatinine increased—Cisplatin—germ cell cancer	0.00186	0.00696	CcSEcCtD
Clodronate—Dehydration—Cisplatin—germ cell cancer	0.00185	0.00691	CcSEcCtD
Clodronate—Pneumonia—Ifosfamide—germ cell cancer	0.00178	0.00668	CcSEcCtD
Clodronate—Anaemia—Vinblastine—germ cell cancer	0.00178	0.00665	CcSEcCtD
Clodronate—Renal failure—Ifosfamide—germ cell cancer	0.00174	0.00653	CcSEcCtD
Clodronate—Pharyngitis—Dactinomycin—germ cell cancer	0.00172	0.00646	CcSEcCtD
Clodronate—Extravasation—Methotrexate—germ cell cancer	0.00172	0.00644	CcSEcCtD
Clodronate—Proteinuria—Methotrexate—germ cell cancer	0.00171	0.00639	CcSEcCtD
Clodronate—Protein urine present—Methotrexate—germ cell cancer	0.00168	0.0063	CcSEcCtD
Clodronate—PTGS2—trigeminal ganglion—germ cell cancer	0.00168	0.00467	CbGeAlD
Clodronate—Oliguria—Methotrexate—germ cell cancer	0.00163	0.00609	CcSEcCtD
Clodronate—PTGS2—embryo—germ cell cancer	0.00163	0.00451	CbGeAlD
Clodronate—Alanine aminotransferase increased—Etoposide—germ cell cancer	0.0016	0.006	CcSEcCtD
Clodronate—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00157	0.00589	CcSEcCtD
Clodronate—Dysphagia—Etoposide—germ cell cancer	0.00157	0.00588	CcSEcCtD
Clodronate—Connective tissue disorder—Ifosfamide—germ cell cancer	0.00157	0.00586	CcSEcCtD
Clodronate—Urethral disorder—Ifosfamide—germ cell cancer	0.00156	0.00584	CcSEcCtD
Clodronate—Bronchospasm—Etoposide—germ cell cancer	0.00155	0.00579	CcSEcCtD
Clodronate—Renal failure—Cisplatin—germ cell cancer	0.0015	0.00563	CcSEcCtD
Clodronate—Anaemia—Bleomycin—germ cell cancer	0.0015	0.00561	CcSEcCtD
Clodronate—Anorexia—Vinblastine—germ cell cancer	0.00149	0.00559	CcSEcCtD
Clodronate—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00144	0.00537	CcSEcCtD
Clodronate—Pneumonia—Etoposide—germ cell cancer	0.00141	0.00528	CcSEcCtD
Clodronate—Anaemia—Dactinomycin—germ cell cancer	0.0014	0.00523	CcSEcCtD
Clodronate—Renal failure—Etoposide—germ cell cancer	0.00138	0.00516	CcSEcCtD
Clodronate—Decreased appetite—Vinblastine—germ cell cancer	0.00136	0.0051	CcSEcCtD
Clodronate—Urinary tract disorder—Cisplatin—germ cell cancer	0.00136	0.00508	CcSEcCtD
Clodronate—Connective tissue disorder—Cisplatin—germ cell cancer	0.00135	0.00505	CcSEcCtD
Clodronate—Urethral disorder—Cisplatin—germ cell cancer	0.00135	0.00504	CcSEcCtD
Clodronate—PTGS2—telencephalon—germ cell cancer	0.00132	0.00367	CbGeAlD
Clodronate—Infection—Bleomycin—germ cell cancer	0.00132	0.00492	CcSEcCtD
Clodronate—Anaemia—Ifosfamide—germ cell cancer	0.00128	0.0048	CcSEcCtD
Clodronate—Angioedema—Ifosfamide—germ cell cancer	0.00127	0.00474	CcSEcCtD
Clodronate—Anorexia—Bleomycin—germ cell cancer	0.00126	0.00472	CcSEcCtD
Clodronate—PTGS2—skin of body—germ cell cancer	0.00126	0.0035	CbGeAlD
Clodronate—Urinary tract disorder—Etoposide—germ cell cancer	0.00124	0.00465	CcSEcCtD
Clodronate—Abdominal pain—Vinblastine—germ cell cancer	0.00124	0.00464	CcSEcCtD
Clodronate—Mediastinal disorder—Cisplatin—germ cell cancer	0.00124	0.00463	CcSEcCtD
Clodronate—Urethral disorder—Etoposide—germ cell cancer	0.00123	0.00462	CcSEcCtD
Clodronate—Infection—Dactinomycin—germ cell cancer	0.00123	0.00459	CcSEcCtD
Clodronate—Dyspnoea—Bleomycin—germ cell cancer	0.00118	0.00442	CcSEcCtD
Clodronate—Renal failure acute—Methotrexate—germ cell cancer	0.00118	0.00442	CcSEcCtD
Clodronate—Anorexia—Dactinomycin—germ cell cancer	0.00118	0.00441	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00117	0.00439	CcSEcCtD
Clodronate—Decreased appetite—Bleomycin—germ cell cancer	0.00115	0.00431	CcSEcCtD
Clodronate—Mediastinal disorder—Etoposide—germ cell cancer	0.00113	0.00424	CcSEcCtD
Clodronate—Infection—Ifosfamide—germ cell cancer	0.00112	0.00421	CcSEcCtD
Clodronate—Anaemia—Cisplatin—germ cell cancer	0.0011	0.00414	CcSEcCtD
Clodronate—Skin disorder—Ifosfamide—germ cell cancer	0.0011	0.00411	CcSEcCtD
Clodronate—PTGS2—uterus—germ cell cancer	0.0011	0.00304	CbGeAlD
Clodronate—Anorexia—Ifosfamide—germ cell cancer	0.00108	0.00404	CcSEcCtD
Clodronate—PTGS2—pituitary gland—germ cell cancer	0.00108	0.00299	CbGeAlD
Clodronate—Decreased appetite—Dactinomycin—germ cell cancer	0.00107	0.00402	CcSEcCtD
Clodronate—Diarrhoea—Vinblastine—germ cell cancer	0.00107	0.00401	CcSEcCtD
Clodronate—Urticaria—Bleomycin—germ cell cancer	0.00105	0.00394	CcSEcCtD
Clodronate—PTGS2—medulla oblongata—germ cell cancer	0.00104	0.00288	CbGeAlD
Clodronate—Anaemia—Etoposide—germ cell cancer	0.00101	0.00379	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00101	0.00378	CcSEcCtD
Clodronate—Dyspnoea—Ifosfamide—germ cell cancer	0.00101	0.00378	CcSEcCtD
Clodronate—Vomiting—Vinblastine—germ cell cancer	0.000997	0.00373	CcSEcCtD
Clodronate—Decreased appetite—Ifosfamide—germ cell cancer	0.000984	0.00368	CcSEcCtD
Clodronate—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000977	0.00366	CcSEcCtD
Clodronate—Abdominal pain—Dactinomycin—germ cell cancer	0.000976	0.00365	CcSEcCtD
Clodronate—Infection—Cisplatin—germ cell cancer	0.000969	0.00363	CcSEcCtD
Clodronate—PTGS2—adrenal gland—germ cell cancer	0.000962	0.00267	CbGeAlD
Clodronate—PTGS2—midbrain—germ cell cancer	0.000949	0.00263	CbGeAlD
Clodronate—Skin disorder—Cisplatin—germ cell cancer	0.000948	0.00355	CcSEcCtD
Clodronate—Pruritus—Bleomycin—germ cell cancer	0.000937	0.00351	CcSEcCtD
Clodronate—Nausea—Vinblastine—germ cell cancer	0.000931	0.00349	CcSEcCtD
Clodronate—PTGS2—bone marrow—germ cell cancer	0.00093	0.00258	CbGeAlD
Clodronate—Anorexia—Cisplatin—germ cell cancer	0.00093	0.00348	CcSEcCtD
Clodronate—PTGS2—spinal cord—germ cell cancer	0.000926	0.00257	CbGeAlD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000926	0.00347	CcSEcCtD
Clodronate—Urticaria—Ifosfamide—germ cell cancer	0.000899	0.00336	CcSEcCtD
Clodronate—PTGS2—female gonad—germ cell cancer	0.000897	0.00249	CbGeAlD
Clodronate—Abdominal pain—Ifosfamide—germ cell cancer	0.000894	0.00335	CcSEcCtD
Clodronate—Infection—Etoposide—germ cell cancer	0.000888	0.00332	CcSEcCtD
Clodronate—Dyspnoea—Cisplatin—germ cell cancer	0.00087	0.00326	CcSEcCtD
Clodronate—Skin disorder—Etoposide—germ cell cancer	0.000868	0.00325	CcSEcCtD
Clodronate—Anorexia—Etoposide—germ cell cancer	0.000852	0.00319	CcSEcCtD
Clodronate—Decreased appetite—Cisplatin—germ cell cancer	0.000848	0.00317	CcSEcCtD
Clodronate—Diarrhoea—Dactinomycin—germ cell cancer	0.000845	0.00316	CcSEcCtD
Clodronate—Pneumonia—Methotrexate—germ cell cancer	0.000844	0.00316	CcSEcCtD
Clodronate—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000842	0.00315	CcSEcCtD
Clodronate—Vomiting—Bleomycin—germ cell cancer	0.000842	0.00315	CcSEcCtD
Clodronate—Rash—Bleomycin—germ cell cancer	0.000835	0.00312	CcSEcCtD
Clodronate—Dermatitis—Bleomycin—germ cell cancer	0.000834	0.00312	CcSEcCtD
Clodronate—PTGS2—endocrine gland—germ cell cancer	0.000834	0.00231	CbGeAlD
Clodronate—Renal failure—Methotrexate—germ cell cancer	0.000825	0.00309	CcSEcCtD
Clodronate—PTGS2—head—germ cell cancer	0.000823	0.00228	CbGeAlD
Clodronate—Pruritus—Ifosfamide—germ cell cancer	0.000801	0.003	CcSEcCtD
Clodronate—Dyspnoea—Etoposide—germ cell cancer	0.000797	0.00298	CcSEcCtD
Clodronate—Nausea—Bleomycin—germ cell cancer	0.000786	0.00294	CcSEcCtD
Clodronate—Vomiting—Dactinomycin—germ cell cancer	0.000785	0.00294	CcSEcCtD
Clodronate—Rash—Dactinomycin—germ cell cancer	0.000779	0.00291	CcSEcCtD
Clodronate—Decreased appetite—Etoposide—germ cell cancer	0.000777	0.00291	CcSEcCtD
Clodronate—Diarrhoea—Ifosfamide—germ cell cancer	0.000774	0.0029	CcSEcCtD
Clodronate—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000772	0.00289	CcSEcCtD
Clodronate—Pharyngitis—Methotrexate—germ cell cancer	0.000748	0.0028	CcSEcCtD
Clodronate—Urinary tract disorder—Methotrexate—germ cell cancer	0.000744	0.00279	CcSEcCtD
Clodronate—Urethral disorder—Methotrexate—germ cell cancer	0.000739	0.00276	CcSEcCtD
Clodronate—PTGS2—cerebellum—germ cell cancer	0.000735	0.00204	CbGeAlD
Clodronate—Nausea—Dactinomycin—germ cell cancer	0.000733	0.00275	CcSEcCtD
Clodronate—Vomiting—Ifosfamide—germ cell cancer	0.000719	0.00269	CcSEcCtD
Clodronate—Rash—Ifosfamide—germ cell cancer	0.000713	0.00267	CcSEcCtD
Clodronate—Dermatitis—Ifosfamide—germ cell cancer	0.000713	0.00267	CcSEcCtD
Clodronate—Urticaria—Etoposide—germ cell cancer	0.00071	0.00266	CcSEcCtD
Clodronate—Abdominal pain—Etoposide—germ cell cancer	0.000706	0.00264	CcSEcCtD
Clodronate—Mediastinal disorder—Methotrexate—germ cell cancer	0.000679	0.00254	CcSEcCtD
Clodronate—Nausea—Ifosfamide—germ cell cancer	0.000672	0.00252	CcSEcCtD
Clodronate—Diarrhoea—Cisplatin—germ cell cancer	0.000667	0.0025	CcSEcCtD
Clodronate—Pruritus—Etoposide—germ cell cancer	0.000632	0.00237	CcSEcCtD
Clodronate—Vomiting—Cisplatin—germ cell cancer	0.00062	0.00232	CcSEcCtD
Clodronate—Rash—Cisplatin—germ cell cancer	0.000615	0.0023	CcSEcCtD
Clodronate—Dermatitis—Cisplatin—germ cell cancer	0.000614	0.0023	CcSEcCtD
Clodronate—Diarrhoea—Etoposide—germ cell cancer	0.000611	0.00229	CcSEcCtD
Clodronate—Anaemia—Methotrexate—germ cell cancer	0.000606	0.00227	CcSEcCtD
Clodronate—PTGS2—brain—germ cell cancer	0.000597	0.00165	CbGeAlD
Clodronate—Nausea—Cisplatin—germ cell cancer	0.000579	0.00217	CcSEcCtD
Clodronate—PTGS2—lymph node—germ cell cancer	0.000576	0.0016	CbGeAlD
Clodronate—Vomiting—Etoposide—germ cell cancer	0.000568	0.00213	CcSEcCtD
Clodronate—Rash—Etoposide—germ cell cancer	0.000563	0.00211	CcSEcCtD
Clodronate—Dermatitis—Etoposide—germ cell cancer	0.000563	0.00211	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000555	0.00208	CcSEcCtD
Clodronate—Infection—Methotrexate—germ cell cancer	0.000532	0.00199	CcSEcCtD
Clodronate—Nausea—Etoposide—germ cell cancer	0.000531	0.00199	CcSEcCtD
Clodronate—Skin disorder—Methotrexate—germ cell cancer	0.00052	0.00195	CcSEcCtD
Clodronate—Anorexia—Methotrexate—germ cell cancer	0.00051	0.00191	CcSEcCtD
Clodronate—Dyspnoea—Methotrexate—germ cell cancer	0.000477	0.00179	CcSEcCtD
Clodronate—Dyspepsia—Methotrexate—germ cell cancer	0.000471	0.00176	CcSEcCtD
Clodronate—Decreased appetite—Methotrexate—germ cell cancer	0.000465	0.00174	CcSEcCtD
Clodronate—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000462	0.00173	CcSEcCtD
Clodronate—Urticaria—Methotrexate—germ cell cancer	0.000425	0.00159	CcSEcCtD
Clodronate—Abdominal pain—Methotrexate—germ cell cancer	0.000423	0.00158	CcSEcCtD
Clodronate—Pruritus—Methotrexate—germ cell cancer	0.000379	0.00142	CcSEcCtD
Clodronate—Diarrhoea—Methotrexate—germ cell cancer	0.000366	0.00137	CcSEcCtD
Clodronate—Vomiting—Methotrexate—germ cell cancer	0.00034	0.00127	CcSEcCtD
Clodronate—Rash—Methotrexate—germ cell cancer	0.000338	0.00126	CcSEcCtD
Clodronate—Dermatitis—Methotrexate—germ cell cancer	0.000337	0.00126	CcSEcCtD
Clodronate—Nausea—Methotrexate—germ cell cancer	0.000318	0.00119	CcSEcCtD
